查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083879

解剖學和病理學市場：按產品、技術、工作流程階段、應用和最終用戶分類－2026-2032年全球市場預測

Anatomic Pathology Market by Product, Technology, Workflow Stage, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，解剖病理學市場將成長至 754.3 億美元，複合年成長率為 8.98%。

主要市場統計數據
基準年 2025 412.9億美元
預計年份：2026年 448億美元
預測年份：2032年 754.3億美元
複合年成長率 (%) 8.98%

解剖病理學是癌症診斷、疾病組織學表徵、移植評估、發炎性疾病檢測和精準醫療的核心。該領域將組織標本轉化為臨床可用的檢體結果，其工作流程涵蓋組織病理學、細胞病理學、免疫組織化學、原位雜合反應、分子病理學、屍檢病理學和外科病理學。

癌症發病率上升、人口老化以及生物標記主導的癌症診療模式的持續發展，從結構上支撐了對病理實驗室的需求。根據國際癌症研究機構（IARC）統計，2022年全球新增癌症病例約2000萬例，癌症相關死亡病例約970萬例，這凸顯了病理檢查室在早期檢測、腫瘤分類、分期、惡性程度分級和治療方案選擇方面發揮的關鍵作用。

此外，市場正基於數位病理學、檢查室自動化、伴隨診斷和人工智慧（AI）影像分析進行重組。隨著檢體量的增加和專業技術水平的區域差異，醫療系統和診斷網路正將檢測結果報告時間、品質保證、病理學家工作效率、綜合報告和組織管理置於優先地位。

解剖病理學部分的變革性變化

解剖病理學領域最顯著的變化是從以顯微鏡為中心的工作流程轉向以數據豐富的診斷生態系統。全切片影像、實驗室資訊系統、影像管理平台和可互通的報告工具​​，使得透過分散式網路進行遠端閱片、腫瘤會診、教學、存檔和品管成為可能。

人工智慧對解剖病理學的累積影響

人工智慧並非取代病理學家，而是為整體解剖病理學帶來累積價值。人工智慧工具正被用於病例優先排序、有絲分裂細胞計數、腫瘤檢測、生物標記量化、品質控制、工作量平衡以及從全切片影像中提取研究級特徵。

全球解剖病理學的主要區域趨勢

北美地區憑藉其較高的癌症篩檢普及率、成熟的醫院網路、大規模參考實驗室、經美國病理學家協會 (CAP) 認證的品管系統以及對數位病理學的早期應用，仍然是解剖病理學領域的領先地區。美國憑藉其腫瘤診斷、大學附屬醫院、檢查室自建檢測 (LDT) 技術和參考實驗室網路，為該地區的發展注入了強勁動力。而加拿大則更注重公共資助的癌症治療方案、省級病理學的現代化以及高品質診斷服務的可及性。

解剖病理學市場中的關鍵群體特定洞察

隨著印尼、泰國、越南、馬來西亞、菲律賓和新加坡不斷擴大醫院容量和癌症治療網路，東協的重要性日益凸顯。新加坡作為區域先進診斷、數位醫療和臨床研究中心，其重要性不容忽視。而大規模的東協市場則需要高度可擴展的病理解決方案，以應對成本效益、勞動力短缺、品質標準化以及檢體從地方城市到中心檢查室的運輸等挑戰。

解剖病理學的關鍵見解

美國是最具影響力的國家市場，這得益於其大規模的癌症醫療網路、私營和學術參考實驗室、CLIA認證的檢測、CAP認證以及對伴隨診斷的積極應用。加拿大則優先考慮集中式癌症計畫、省級品質標準和公平的診斷管道。同時，墨西哥和巴西正在擴展其公立和私立診斷系統，以滿足其龐大且地理分散的人口日益成長的腫瘤治療需求。

解剖病理學領域領導者使用的實用建議

產業領導者應優先考慮端到端工作流程的現代化，而非僅採用某項技術。成功的方案應整合檢體追蹤、宏觀觀察、組織處理、染色、切片掃描、報告撰寫、存檔和品管等環節，並將其與生產力、時間效率和診斷品質等可衡量的結果掛鉤。

解剖學和病理學分析的調查方法

本執行摘要是根據公開權威來源的二手研究，包括世界衛生組織 (WHO)、國際癌症研究機構 (IARC)、美國食品藥物管理局(FDA)、醫療保險和醫療補助服務中心 (CMS)、美國病理學家協會 (CAP)、歐洲委員會、國家癌症控制機構、同行評審資訊來源以及主要醫療保健系統的出版刊物。

結論：解剖病理學的未來

解剖病理學正從主要依賴手工診斷的專科轉變為以數位化和生物標記主導的精準醫療基礎學科。由於癌症發病率上升、組織活體組織切片範圍擴大以及對更快、更可重複診斷的需求日益成長，其在整個醫療保健系統中的作用也變得越來越重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 解剖病理學市場：依產品分類

  • 設備/器材
    • 玻片染色系統
    • 組織處理系統
    • 嵌入式系統
    • 切片機
    • 病理掃描儀
    • 顯微鏡
    • 解剖站
    • 組織勻漿器
  • 試劑和耗材
    • 抗體和試劑
    • 成套工具
    • 滑蓋玻璃
    • 盒式包埋劑
  • 服務
    • 外部測試實驗室服務
    • 維護支援
  • 軟體和分析工具
    • 影像分析軟體
    • 實驗室資訊系統
    • 病理影像檢視器

第8章 解剖病理學市場：依技術分類

  • 數位病理學
  • 免疫組織化學
  • 原位雜合
  • 分子診斷
  • 特殊染色

第9章：解剖病理市場：依工作流程階段分類

  • 檢體前分析
  • 組織處理和包埋
  • 切片
  • 染色和標記
  • 影像分析
  • 觀察的解釋和報告

第10章 解剖病理學市場：依應用領域分類

  • 疾病診斷
    • 癌症
    • 感染疾病
    • 神經病變
    • 心血管疾病
  • 藥物發現與開發
  • 學術與研究

第11章 解剖學和病理學市場：按最終用戶分類

  • 醫院
  • 診斷實驗室
  • 門診手術中心
  • 製藥和生物技術公司
  • 學術研究機構

第12章 解剖學和病理學市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 解剖學和病理學市場：按組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 解剖學和病理學市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Labcorp Holdings Inc.
  • Sonic Healthcare Limited
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • SYNLAB AG
  • PHC Holdings Corporation
  • Siemens Healthineers AG
  • BIOMERIEUX
  • Neogenomics Laboratories, Inc.
  • Sysmex Corporation
  • Abbott Laboratories
  • Hologic, Inc.
  • ARUP Laboratories
  • Avantik
  • Bio-Techne Corporation
  • Biocare Medical, LLC
  • Cardinal Health
  • Cell Signaling Technology, Inc.
  • Cerba Research NV
  • Charles River Laboratories International, Inc.
  • Epredia
  • FUJIFILM Holdings Corporation
  • GPI SpA
  • Guardant Health, Inc.
  • Healthscope Ltd.
  • Inpeco SA
  • Koninklijke Philips NV
  • LigoLab Information Systems
  • Milestone SPA
  • Molecular Pathology Laboratory Network, Inc.
  • Propath UK Limited
  • Proscia Inc.
  • Sakura Seiki Co., Ltd.
  • Techcyte, Inc.
  • Unilabs SA
  • Veracyte, Inc.
  • Visiant Health
Product Code: MRR-431F213C9077

The Anatomic Pathology Market is projected to grow by USD 75.43 billion at a CAGR of 8.98% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.29 billion
Estimated Year [2026] USD 44.80 billion
Forecast Year [2032] USD 75.43 billion
CAGR (%) 8.98%

Anatomic pathology sits at the center of cancer diagnosis, tissue-based disease characterization, transplant evaluation, inflammatory disease workups, and precision medicine. The discipline spans histopathology, cytopathology, immunohistochemistry, in situ hybridization, molecular pathology, autopsy pathology, and surgical pathology workflows that convert tissue specimens into clinically actionable diagnoses.

Demand is structurally supported by rising cancer incidence, aging populations, and the continued expansion of biomarker-driven oncology. The International Agency for Research on Cancer reported about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, reinforcing the indispensable role of pathology laboratories in early detection, tumor classification, staging, grading, and therapy selection.

The market is also being reshaped by digital pathology, laboratory automation, companion diagnostics, and artificial intelligence-enabled image analysis. Health systems and diagnostic networks are prioritizing turnaround time, quality assurance, pathologist productivity, integrated reporting, and tissue stewardship as specimen volumes increase and subspecialty expertise remains unevenly distributed across geographies.

Transformative Shifts in the Anatomic Pathology Landscape

The most important shift in anatomic pathology is the movement from microscope-centered workflows to data-rich diagnostic ecosystems. Whole slide imaging, laboratory information systems, image management platforms, and interoperable reporting tools are enabling remote review, tumor boards, education, archiving, and quality control across distributed networks.

Precision oncology is another major force. Immunohistochemistry, fluorescence in situ hybridization, next-generation sequencing triage, and companion diagnostic testing are increasingly embedded in routine tissue workflows. This is raising expectations for standardized pre-analytics, validated assays, tissue stewardship, and faster reflex testing pathways that preserve limited biopsy material.

Regulation is becoming more consequential. In the United States, CLIA oversight, College of American Pathologists accreditation, and the FDA's 2024 final rule on laboratory developed tests are influencing validation, documentation, and risk management. In Europe, the In Vitro Diagnostic Regulation is reshaping conformity assessment and evidence expectations for diagnostic products used in pathology laboratories.

Cumulative Impact of Artificial Intelligence in Anatomic Pathology

Artificial intelligence is adding cumulative value across anatomic pathology rather than replacing pathologists. AI-assisted tools are being applied to case prioritization, mitotic counting, tumor detection, biomarker quantification, quality checks, workload balancing, and research-grade feature extraction from whole slide images.

Regulatory milestones have validated the clinical direction of the field. The U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnostic use in 2017, and subsequent clearances for AI-assisted pathology applications have demonstrated growing acceptance of software as a medical device when supported by analytical and clinical validation.

The cumulative impact is operational and clinical. AI can reduce repetitive measurement burden, flag regions of interest, improve reproducibility in quantitative assays, and support subspecialty consultation in underserved areas. However, adoption depends on scanner standardization, data governance, cybersecurity, algorithm monitoring, bias assessment, pathologist oversight, and clear reimbursement or productivity justification.

Key Regional Insights Across Global Anatomic Pathology

North America remains a leading region for anatomic pathology because of high cancer screening uptake, mature hospital networks, reference laboratory scale, CAP-accredited quality systems, and early adoption of digital pathology. The United States drives much of the regional momentum through oncology diagnostics, academic medical centers, laboratory developed testing expertise, and reference laboratory networks, while Canada emphasizes publicly funded cancer care pathways, provincial pathology modernization, and quality-based diagnostic access.

Europe combines strong academic pathology expertise with regulatory transformation under the EU In Vitro Diagnostic Regulation. Germany, France, Italy, Spain, and the United Kingdom are advancing cancer diagnostics, biobanking, digital health infrastructure, and genomics-enabled care, although procurement cycles, workforce pressures, and data protection requirements can slow implementation. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems address growing cancer burdens, urban hospital capacity, organized screening initiatives, and the need for standardized pathology quality.

Latin America, the Middle East, and Africa show rising need for tissue diagnostics tied to oncology expansion, infectious disease pathology, and increasing use of immunohistochemistry and molecular testing, but access remains uneven. Brazil and Mexico anchor Latin American demand through large public and private healthcare networks, Middle Eastern countries are investing in tertiary care, oncology centers, and laboratory accreditation, and African markets are focused on workforce development, sample logistics, external quality assessment, and regional reference testing models to improve access to reliable anatomic pathology services.

Key Group Insights for Anatomic Pathology Markets

ASEAN is gaining importance as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore expand hospital capacity and cancer care networks. Singapore acts as a regional hub for advanced diagnostics, digital health, and clinical research, while larger ASEAN markets require scalable pathology solutions that address affordability, workforce shortages, quality standardization, and specimen transport from secondary cities to centralized laboratories.

The GCC is investing in advanced tertiary care, oncology centers, laboratory accreditation, and digital health platforms, making it a significant corridor for premium pathology instrumentation, outsourced diagnostic partnerships, and quality-led modernization. The European Union is shaped by IVDR compliance, cross-border research programs, cancer mission initiatives, and strong public health systems, creating demand for validated diagnostics, traceable workflows, interoperable data systems, and evidence-based digital pathology adoption.

BRICS countries represent high-volume pathology environments because Brazil, Russia, India, China, and South Africa combine large patient populations with expanding oncology infrastructure and variable access to subspecialty expertise. G7 markets remain innovation leaders in digital pathology, molecular integration, clinical validation, and AI governance. NATO countries overlap substantially with advanced North American and European diagnostic systems, where resilience, cybersecurity, continuity planning, and secure medical data infrastructure are increasingly relevant to laboratory modernization.

Key Country Insights in Anatomic Pathology

The United States is the most influential country market, supported by large cancer care networks, commercial and academic reference laboratories, CLIA-certified testing, CAP accreditation, and strong adoption of companion diagnostics. Canada prioritizes centralized cancer programs, provincial quality standards, and equitable diagnostic pathways, while Mexico and Brazil are expanding private and public diagnostic capacity to address rising oncology needs across large and geographically diverse populations.

In Europe, the United Kingdom has invested in genomics, cancer diagnostic capacity, and digital pathology initiatives through the National Health Service, while Germany benefits from advanced laboratory infrastructure, strong medical technology adoption, and established pathology expertise. France, Italy, and Spain combine universal health systems with active cancer screening, hospital-based pathology networks, and increasing interest in molecular pathology, while Russia maintains demand through large tertiary hospitals and oncology centers despite procurement and geopolitical constraints.

China and India are high-priority anatomic pathology markets due to large disease burdens, hospital expansion, growing cancer screening activity, and increasing use of immunohistochemistry, histochemistry, and molecular pathology. Japan and South Korea are advanced markets with strong cancer diagnostics, automation, digital health capacity, and precision medicine infrastructure, while Australia benefits from organized cancer screening, high-quality pathology standards, accreditation culture, and regional leadership in digital health implementation.

Actionable Recommendations for Anatomic Pathology Leaders

Industry leaders should prioritize end-to-end workflow modernization rather than isolated technology purchases. Successful programs link specimen tracking, grossing, tissue processing, staining, slide scanning, reporting, archiving, and quality management into measurable productivity, turnaround time, and diagnostic quality outcomes.

Vendors and laboratories should invest in regulatory-grade validation, cybersecurity, interoperability, and pathologist-centered design. AI deployment should begin with high-value use cases such as triage, quality control, biomarker quantification, and workload optimization, with post-implementation monitoring, documented performance metrics, and transparent governance.

Commercial strategies should be region-specific. Mature markets need differentiated digital pathology platforms, automation, integrated molecular workflows, and evidence-based AI, while emerging markets need affordable instruments, training, remote consultation networks, external quality assessment, and accredited reference laboratory partnerships that improve access without compromising diagnostic quality.

Research Methodology for Anatomic Pathology Analysis

This executive summary is based on secondary research from publicly available and authoritative sources, including the World Health Organization, International Agency for Research on Cancer, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, College of American Pathologists, European Commission, national cancer agencies, peer-reviewed literature, and major health system publications.

The analysis evaluates market drivers, regulatory developments, technology adoption, regional health infrastructure, workforce considerations, and country-level diagnostic capacity. Insights were cross-checked against recognized clinical and policy references to avoid unsupported assumptions and to ensure that the conclusions reflect verifiable trends in anatomic pathology, digital pathology, AI-enabled diagnostics, laboratory automation, and precision oncology.

Conclusion: The Future of Anatomic Pathology

Anatomic pathology is evolving from a predominantly manual diagnostic specialty into an integrated, digitally enabled, and biomarker-driven foundation of precision medicine. Rising cancer incidence, expanding tissue-based testing, and growing demand for faster and more reproducible diagnoses are strengthening its role across healthcare systems.

The next phase of leadership will favor organizations that combine scientific rigor, workflow efficiency, regulatory readiness, interoperability, and responsible AI adoption. Laboratories, technology vendors, and healthcare providers that align innovation with quality, access, data security, and clinical trust will be best positioned to create long-term value in global anatomic pathology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anatomic Pathology Market, by Product

  • 7.1. Instruments & Equipment
    • 7.1.1. Slide-Staining Systems
    • 7.1.2. Tissue Processing Systems
    • 7.1.3. Embedding Systems
    • 7.1.4. Microtomes
    • 7.1.5. Pathology Scanners
    • 7.1.6. Microscopes
    • 7.1.7. Grossing Stations
    • 7.1.8. Tissue Homogenizers
  • 7.2. Reagents & Consumables
    • 7.2.1. Antibodies & Reagents
    • 7.2.2. Kits
    • 7.2.3. Slides & Coverslips
    • 7.2.4. Cassettes & Embedding Media
  • 7.3. Services
    • 7.3.1. Reference Laboratory Services
    • 7.3.2. Maintenance & Support
  • 7.4. Software & Analysis Tools
    • 7.4.1. Image Analysis Software
    • 7.4.2. Laboratory Information Systems
    • 7.4.3. Pathology Viewers

8. Anatomic Pathology Market, by Technology

  • 8.1. Digital Pathology
  • 8.2. Immunohistochemistry
  • 8.3. In Situ Hybridization
  • 8.4. Molecular Diagnostics
  • 8.5. Special Staining

9. Anatomic Pathology Market, by Workflow Stage

  • 9.1. Specimen Pre-Analytics
  • 9.2. Tissue Processing & Embedding
  • 9.3. Microtomy
  • 9.4. Staining & Labeling
  • 9.5. Image Analysis
  • 9.6. Interpretation & Reporting

10. Anatomic Pathology Market, by Application

  • 10.1. Disease Diagnosis
    • 10.1.1. Cancer
    • 10.1.2. Infectious Diseases
    • 10.1.3. Neurological Disorders
    • 10.1.4. Cardiovascular Diseases
  • 10.2. Drug Discovery & Development
  • 10.3. Academic & Research

11. Anatomic Pathology Market, by End User

  • 11.1. Hospitals
  • 11.2. Diagnostic Laboratories
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Pharmaceuticals & Biotechnology Companies
  • 11.5. Academic & Research Institutes

12. Anatomic Pathology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Anatomic Pathology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Anatomic Pathology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. F. Hoffmann-La Roche Ltd
  • 16.2. Danaher Corporation
  • 16.3. Labcorp Holdings Inc.
  • 16.4. Sonic Healthcare Limited
  • 16.5. Quest Diagnostics Incorporated
  • 16.6. Agilent Technologies, Inc.
  • 16.7. SYNLAB AG
  • 16.8. PHC Holdings Corporation
  • 16.9. Siemens Healthineers AG
  • 16.10. BIOMERIEUX
  • 16.11. Neogenomics Laboratories, Inc.
  • 16.12. Sysmex Corporation
  • 16.13. Abbott Laboratories
  • 16.14. Hologic, Inc.
  • 16.15. ARUP Laboratories
  • 16.16. Avantik
  • 16.17. Bio-Techne Corporation
  • 16.18. Biocare Medical, LLC
  • 16.19. Cardinal Health
  • 16.20. Cell Signaling Technology, Inc.
  • 16.21. Cerba Research NV
  • 16.22. Charles River Laboratories International, Inc.
  • 16.23. Epredia
  • 16.24. FUJIFILM Holdings Corporation
  • 16.25. GPI S.p.A.
  • 16.26. Guardant Health, Inc.
  • 16.27. Healthscope Ltd.
  • 16.28. Inpeco SA
  • 16.29. Koninklijke Philips N.V.
  • 16.30. LigoLab Information Systems
  • 16.31. Milestone SPA
  • 16.32. Molecular Pathology Laboratory Network, Inc.
  • 16.33. Propath UK Limited
  • 16.34. Proscia Inc.
  • 16.35. Sakura Seiki Co., Ltd.
  • 16.36. Techcyte, Inc.
  • 16.37. Unilabs SA
  • 16.38. Veracyte, Inc.
  • 16.39. Visiant Health

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANATOMIC PATHOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANATOMIC PATHOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANATOMIC PATHOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANATOMIC PATHOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANATOMIC PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROTOMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MICROTOMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROTOMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GROSSING STATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GROSSING STATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GROSSING STATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPECIAL STAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPECIAL STAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPECIAL STAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MICROTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MICROTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MICROTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STAINING & LABELING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STAINING & LABELING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STAINING & LABELING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 261. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 338. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 339. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 348. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 349. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 350. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 355. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 356. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 357. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 358. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 359. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 360. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 361. RUSSIA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)